Although both enzymes modulate the immune response through m6A-dependent mechanisms, accumulating evidence suggests that ALKBH5 exerts a more prominent role in shaping the tumor immune microenvironment, particularly by regulating immune checkpoint expression and T cell infiltration. The gene discussed is ALKBH5; the disease is neoplasm.